Bibliography

Filters: Keyword is Patient Participation  [Clear All Filters]
U
Understanding Health Technology Assessment (HTA) . Health Equality Europe (HEE) ; 2008. Abstract
T
Basch E. Toward patient-centered drug development in oncology. N Engl J Med. 2013;369(5):397-400.
S
Basch E. Systematic collection of patient-reported adverse drug reactions: a path to patient-centred pharmacovigilance. Drug Saf. 2013;36(4):277-8.
Stakeholder Engagement. Washington (USA): Washington State Health Care Authority ; 2014. Abstract
R
Menon D, Stafinski T. Role of patient and public participation in health technology assessment and coverage decisions. Expert Rev Pharmacoecon Outcomes Res. 2011;11(1):75-89. Abstract
Hubbard G, Kidd L, Donaghy E, McDonald C, Kearney N. A review of literature about involving people affected by cancer in research, policy and planning and practice. Patient Educ Couns. 2007;65(1):21-33. Abstract
P
Public and patient involvement. Southampton: NIHR Evaluation, Trials and Studies Coordinating Centre (NETSCC); 2014. Abstract
Bridges JF, Jones C. Patient-based health technology assessment: a vision of the future. Int J Technol Assess Health Care. 2007;23(1):30-5. Abstract
Patient Involvement in Clinical Research: A guide for Patient Organisations and Patient Representatives. Soest (NL): PatientPartner; 2011. Abstract
I
Gagnon M-, Gagnon J, St-Pierre M, Gauvin F-, Piron F, Rhainds M, et al. Involving patients in HTA activities at local level: a study protocol based on the collaboration between researchers and knowledge users. BMC Health Serv Res. 2012;12:14. Abstract
Hailey D, Werkö S, Bakri R, Cameron A, Göhlen B, Myles S, et al. Involvement of consumers in health technology assessment activities by Inahta agencies. Int J Technol Assess Health Care. 2013;29(1):79-83. Abstract
Gagnon M-, Lepage-Savary D, Gagnon J, St-Pierre M, Simard C, Rhainds M, et al. Introducing patient perspective in health technology assessment at the local level. BMC Health Serv Res. 2009;9:54. Abstract
Whitty JA. An international survey of the public engagement practices of health technology assessment organizations. Value Health. 2013;16(1):155-63. Abstract
Danner M, Hummel MJ, Volz F, van Manen JG, Wiegard B, Dintsios C-, et al. Integrating patients' views into health technology assessment: Analytic hierarchy process (AHP) as a method to elicit patient preferences. Int J Technol Assess Health Care. 2011;27(4):369-75. Abstract
iap2 public participation spectrum. Louisville (CO, USA): International Association for Public Participation (IAP2); 2013. Abstract
H
Strech D. How factual do we want the facts? Criteria for a critical appraisal of empirical research for use in ethics. J Med Ethics. 2010;36(4):222-5. Abstract
Izquierdo F, Gracia J, Guerra M, Blasco JA, Andradas E. Health technology assessment-based development of a Spanish breast cancer patient decision aid. Int J Technol Assess Health Care. 2011;27(4):363-8. Abstract
Fattal J, Lehoux P. Health technology assessment use and dissemination by patient and consumer groups: why and how? Int J Technol Assess Health Care. 2008;24(4):473-80. Abstract
G
Staniszewska S, Brett J, Mockford C, Barber R. The GRIPP checklist: strengthening the quality of patient and public involvement reporting in research. Int J Technol Assess Health Care. 2011;27(4):391-9. Abstract
Get Involved. London (UK): National Institute for Health and Care Excellence (NICE); 2014. Abstract
E
European Patients‘ Academy on Therapeutic Innovation (EUPATI). European Patients‘ Academy on Therapeutic Innovation (EUPATI); 2013. Abstract
eMeet - e Medicine Evaluation Educational Training. Eli Lilly and Company; 2014. Abstract
D
Direction collaboration et partenariat patient. Montréal: Université de Montréal; 2014. Abstract
B
Basch E. Beyond the FDA PRO guidance: steps toward integrating meaningful patient-reported outcomes into regulatory trials and US drug labels. Value Health. 2012;15(3):401-3.
A
Drummond M, Tarricone R, Torbica A. Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract